Key points are not available for this paper at this time.
This study underpins the poor pharmacotherapeutic prognosis of PTTN. The results support findings on neuropathic pain in other sites and point to the need for further research and reexamination of current PTTN treatment protocols.
Haviv et al. (Wed,) studied this question.